Vemircopan in Untreated PNH
Phase II Trial of Vemircopan (ALXN2050) Monotherapy for Paroxysmal Nocturnal Hemoglobinuria

Released: December 16, 2022

Expiration: December 15, 2023

Activity

Progress
1
Course Completed